K. Van Kolen

Papers

Total Citations

H-Index

About

K. Van Kolen is a researcher whose work centers on the molecular pathology and clinical management of thymic epithelial tumors, with a particular focus on thymoma. Their major contribution lies in synthesizing and evaluating the complex interplay of prognostic factors and genetic markers that influence thymoma staging and patient outcomes. In their highly cited 2010 review, Van Kolen critically assessed the impact of variables such as paraneoplastic syndromes, patient age and gender, histological classification, capsular invasion, and surgical treatment on prognosis. This work, which has garnered 18 citations, serves as a foundational reference for clinicians and researchers seeking to understand the multifactorial nature of thymoma progression. By integrating genetic markers with traditional clinical factors, Van Kolen has helped bridge the gap between molecular biology and surgical oncology, providing a clearer roadmap for risk stratification. Their research remains a key resource for those investigating how to refine staging systems and personalize treatment strategies for this rare but complex thoracic malignancy.